The critical need for cancer biometrics: quantitative, reproducible measures of cancer to define response to therapy
Lotze, M.T.
Current Opinion in Investigational Drugs 4(6): 649-651
2003
ISSN/ISBN: 1472-4472 PMID: 12901221 Document Number: 555467
Document emailed within 1 workday
Related Documents
Miglietta, L.; Cannobbio, L.; Boccardo, F. 1995: Assessment of response to carboplatin in patients with hormone-refractory prostate cancer: a critical analysis of drug activity Anticancer Research 15(6b): 2825-2828Matthay, R.A. 1982: Immunoadjuvant therapy for lung cancer. a critical review Clinics in Chest Medicine 3(2): 423-441
Honda, M. 2008: International standards of cancer treatment: looking back on patient activities that led to the Basic Act for Anti-Cancer Measures Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(3): 402-405
Lippman, M.E.; Allegra, J.C. 1980: Quantitative estrogen receptor analyses: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval Cancer 46(12 Suppl): 2829-2834
Geiser, A.J.; Al-Khamis, A.; Patel, S.; Sugrue, J.; Borsuk, D.J.; Marecik, S.; Kochar, K.; Park, J.J. 2019: Rectal Cancer Complete Response Outcomes in a Community-Based Hospital Comparable with Large Cancer Centers when Multidisciplinary Approach to Rectal Cancer Is Used American Surgeon 85(5): 530-538
Peto, R. 1983: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today NATO advanced study institutes series Series A Life sciences 60: 587-593
Izumi, M.; Iino, Y.; Yokoe, T.; Inoue, T.; Yamada, T.; Kobayashi, I.; Andoh, T.; Yokota, T.; Iijima, T.; Morishita, Y. 1994: Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(2): 265-268
Basilico, V.; Griffa, B.; Radaelli, F.; Zanardo, M.; Rossi, F.; Caizzone, A.; Vannelli, A. 2014: Anastomotic leakage following colorectal resection for cancer: how to define, manage and treat it Minerva Chirurgica 69(5): 245-252
De Almagro, M.C.; Vucic, D. 2012: The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy Experimental Oncology 34(3): 200-211
Shimazaki, J.; Isaka, S.; Akimoto, S.; Sumiya, H.; Masai, M.; Higa, T. 1990: Investigating the response of prostatic cancer to endocrine therapy Progress in Clinical and Biological Research 357: 59-67
Quesada, J.R. 1989: Biologic response modifiers in cancer therapy: a review Texas Medicine 85(11): 42-47
Silvestrini, R.; Costa, A.; Faranda, A. 1996: Biological prospectives to define prognosis and treatment strategies in liver metastases from colorectal cancer Annali Italiani di Chirurgia 67(6): 733-737
Fukuda, Y.; Fujio, N.; Ihara, T.; Takatori, H.; Tsukazaki, T.; Koyama, I.; Tsukazaki, Y.; Osugi, H. 2005: A case of cecal cancer with multiple liver metastases responding to irinotecan (CPT-11)/cisplatin (CDDP) combination therapy for elevation of CA19-9 after complete response (CR) by l-leucovorin(LV)/5-fluorouracil(5-FU) therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(12): 1949-1952
Lüscher, N.J. 1992: Reconstructive measures in local recurrence after breast saving therapy of breast cancer Helvetica Chirurgica Acta 59(1): 181-187
Sutherland, C.M.; Muchmore, J.H.; Carter, R.D. 1985: Response to aminoglutethimide after failure of tamoxifen therapy in breast cancer Southern Medical Journal 78(8): 987-989
Oliver, R.T.; Nouri, A.M. 1992: T cell immune response to cancer in humans and its relevance for immunodiagnosis and therapy Cancer Surveys 13: 173-204
Reuter, V.E. 1990: Pathology of bladder cancer: assessment of prognostic variables and response to therapy Seminars in Oncology 17(5): 524-532
Shimoyama, S.; Aoki, F.; Kojima, J.; Kaminishi, M. 1999: A case of complete response to esophageal cancer by a novel concurrent chemoradiation therapy Hepato-Gastroenterology 46(28): 2409-2413
Andrés, E.; Goichot, B.; Kurtz, J.E.; Dufour, P.; Imler, M.; Schlienger, J.L. 1999: Carcinomatous meningitis secondary to breast cancer. Spectacular response to hormone therapy Presse Medicale 28(2): 75
Royal, R.E.; Steinberg, S.M.; Krouse, R.S.; Heywood, G.; White, D.E.; Hwu, P.; Marincola, F.M.; Parkinson, D.R.; Schwartzentruber, D.J.; Topalian, S.L.; Yang, J.C.; Rosenberg, S.A. 1996: Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma Cancer Journal from Scientific American 2(2): 91-98